HomeBusiness NewsAN2 Therapeutics, Inc. Reports Inducement Grants under Listing Rule 5635(c)(4)

AN2 Therapeutics, Inc. Reports Inducement Grants under Listing Rule 5635(c)(4)

September 17, 2026

- Advertisement -

MENLO PARK, Calif.–(BUSINESS WIRE)–AN2 Therapeutics, Inc. (NASDAQ: ANTX), a clinical-stage biopharmaceutical company developing novel small molecule therapeutics derived from its boron chemistry platform, today announced it granted inducement equity awards to Cameron Trenor, M.D., the…

Click here to view the original article.

Tags
Business Wire

- Advertisment -

Fire investigation at New Town

Woman charged over alleged ‘cash for demerit points’ fraud scheme

AN2 Therapeutics, Inc. Reports Inducement Grants under Listing Rule 5635(c)(4)

Recently Viewed

GALLERY: bridges built across schools to break decade-long musical drought

Why mighty Mauritius remains a high-society haven, decades after the first jet-set boom

AFL teams: Heartbreak as Swans veteran Harry Cunningham ruled out of preliminary final

Queensland 18-year-old charged with extremist offences for alleged social media targeting of Muslims and Jews

FEATURED

Great White shark bites fishing boat off Sunshine Coast

Volcanic cloud from Whakaari White Island halts flights

Great Koala Count: Aussies urged to track sightings of iconic marsupials

POPULAR POSTS

WA Government wins court fight to keep trans woman in male prison

What if giving away a day’s revenue was the best day of your year?

How does the menopause drug Veoza work? And how is it different to hormone therapy?

POPULAR CATEGORY

FOLLOW US

AN2 Therapeutics, Inc. Reports Inducement Grants under Listing Rule 5635(c)(4)

RELATED ARTICLES

Recently Viewed

FEATURED

POPULAR POSTS

POPULAR CATEGORY

FOLLOW US